Transgenic models and subcellular pathology - Do they tell us what goes wrong in Huntington's disease?

Molecular Psychiatry

Volumn 3, Issue 3, 1998, Pages 192-195

  Reynolds, G P ^a   Dalton, C F ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; HUNTINGTON CHOREA; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TRANSGENIC MOUSE; TRINUCLEOTIDE REPEAT;

EID: 0031802550     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000374     Document Type: Short Survey

References (25)

1. Beal MF. Neurochemistry and toxin models in Huntington's disease. Curr Opin Neurol 1994; 7: 542-547.
2. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM et al. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 1997; 41: 646-653.
3. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983; 306: 234-238.
4. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
5. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Forntali M et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet 1993; 4: 387-392.
6. Sharp AH, Loev SJ, Schilling G, Li S-H, Li X-J, Bao J et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995; 14: 1065-1074.
7. Landwehrmeyer GB, McNeil SM, Dure LS, Ge P, Alzawa H, Huang Q et al. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 1995; 37: 218-230.
8. Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y et al. Cellular localisation of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet 1995; 10: 104-110.
9. DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 1995; 14: 1075-1081.
10. Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeill SM et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 1995; 269: 407-410.
11. Burke JR, Enghild JJ, Martin ME, Jou YS, Myers RM, Roses AD et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med 1996; 2: 347-350.
12. Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA et al. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci USA 1996; 93: 3037-5042.
13. Li XJ, Li SH, Sharp AH, Nucifora Jr FC, Schilling G, Lanahan A et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 1995; 378: 398-402.
14. Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K et al. HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet 1997; 16: 44-53.
15. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493-506.
16. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997; 90: 537-548.
17. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuntes in brain. Science 1997; 277: 1990-1993.
18. Lange H, Thörner G, Hopf A, Schröder KF. Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 1976; 28: 401-425.
19. Jeste DV, Barban L, Parisi J. Reduced Purkinje cell density in Huntington's disease. Exp Neurol 1984; 85: 78-86.
20. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997; 19: 333-344.
21. Skinner PJ, Koshy BT, Cummings CJ, Klement IA, Helin K, Servadio A et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997; 389: 971-974.
22. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet 1996; 13: 442-449.
23. Matilla A, Koshy BT, Cummings CJ, Isobe T, Orr HT, Zoghbi HY. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 1997; 389: 974-978.
24. Jackson M, Gentleman S, Lennox G, Ward L, Gray T, Randall K et al. The cortical neuritic pathology of Huntington's disease. Neuropathol Appl Neurobiol 1995; 21: 18-26.
25. Shelbourne PF, Killeen N, Hevner R, Tecott L, Runenstein J, Lewandowski M et al. Modeling Huntington disease in mice. Am J Hum Genet 1996; 59 (suppl): A284 (abstract).